TY - JOUR
T1 - Ocular manifestations of systemic malignancies
AU - Solomon, Sharon D.
AU - Hasenyager Smith, Jennifer
AU - O'Brien, Joan
PY - 1999/12/15
Y1 - 1999/12/15
N2 - Ocular manifestations of systemic malignancy are important for both the ophthalmologist and the internist to recognize because they may precede the diagnosis of cancer. This review of the current literature discusses the clinical manifestations etiology, and potential therapeutic interventions for a group of visual paraneoplastic syndromes, including carcinoma-associated retinopathy and melanoma-associated retinopathy. These conditions are characterized by elevated serum levels of autoantibodies directed against tumor antigen that cross-react with retinal proteins, resulting in rod and cone dysfunction. The clinical presentation, site of origin, frequency, and intraocular distribution of tumors metastatic to the eye are also reviewed.
AB - Ocular manifestations of systemic malignancy are important for both the ophthalmologist and the internist to recognize because they may precede the diagnosis of cancer. This review of the current literature discusses the clinical manifestations etiology, and potential therapeutic interventions for a group of visual paraneoplastic syndromes, including carcinoma-associated retinopathy and melanoma-associated retinopathy. These conditions are characterized by elevated serum levels of autoantibodies directed against tumor antigen that cross-react with retinal proteins, resulting in rod and cone dysfunction. The clinical presentation, site of origin, frequency, and intraocular distribution of tumors metastatic to the eye are also reviewed.
UR - http://www.scopus.com/inward/record.url?scp=0032744918&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032744918&partnerID=8YFLogxK
U2 - 10.1097/00055735-199912000-00013
DO - 10.1097/00055735-199912000-00013
M3 - Article
C2 - 10662250
AN - SCOPUS:0032744918
SN - 1040-8738
VL - 10
SP - 447
EP - 451
JO - Current opinion in ophthalmology
JF - Current opinion in ophthalmology
IS - 6
ER -